<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:3d5230ee-5005-42d8-9e7e-60622adb9f4a,g:2f1a635e-cc44-4709-bc93-36e71fb2f55c,d:63325b1931d343a7922529b5b4797bed--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>zsan-20220510</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF80L2ZyYWc6ZmZiZTExYzhjYmE1NDhlM2E2NDdhYzkyN2M4MGQzM2IvdGFibGU6MWMzN2U4MDYxMjU5NDQ0OGIzMmUzNDIyZTBiNDg4MTQvdGFibGVyYW5nZToxYzM3ZTgwNjEyNTk0NDQ4YjMyZTM0MjJlMGI0ODgxNF8wLTEtMS0xLTMzMTkz_c2de38e1-c4bf-4c53-a193-0bd7363db1c6">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF80L2ZyYWc6ZmZiZTExYzhjYmE1NDhlM2E2NDdhYzkyN2M4MGQzM2IvdGFibGU6MWMzN2U4MDYxMjU5NDQ0OGIzMmUzNDIyZTBiNDg4MTQvdGFibGVyYW5nZToxYzM3ZTgwNjEyNTk0NDQ4YjMyZTM0MjJlMGI0ODgxNF8xLTEtMS0xLTMzMTkz_4c4a26a4-441f-4ff5-93f0-305e4a28e96b">0001587221</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="zsan-20220510.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib800c4943b614950b189416f73dc7e99_D20210311-20210311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001587221</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-11</xbrli:startDate><xbrli:endDate>2021-03-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i63325b1931d343a7922529b5b4797bed_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8xMzM4_2eed6122-c0f0-46de-ae1c-4e4ba0bd9498">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8yMzI_cd25259c-d4a2-42bd-8f9f-e25a32a41108">May 10, 2022</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8xMzM5_eb0688a0-c324-4181-9a9a-f1ca4b65b2ca">ZOSANO PHARMA CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6MGE0MzU0Y2FiN2JiNDQ4MmI1MDMzNjE2Mzc5ZWZmZmQvdGFibGVyYW5nZTowYTQzNTRjYWI3YmI0NDgyYjUwMzM2MTYzNzllZmZmZF8wLTAtMS0xLTMzMTkz_cc45caa1-a30f-440e-b9d1-e6669af93a48">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6MGE0MzU0Y2FiN2JiNDQ4MmI1MDMzNjE2Mzc5ZWZmZmQvdGFibGVyYW5nZTowYTQzNTRjYWI3YmI0NDgyYjUwMzM2MTYzNzllZmZmZF8wLTItMS0xLTMzMTkz_b04622d0-9c46-4571-9c6f-9608c5dd72e1">001-36570</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6MGE0MzU0Y2FiN2JiNDQ4MmI1MDMzNjE2Mzc5ZWZmZmQvdGFibGVyYW5nZTowYTQzNTRjYWI3YmI0NDgyYjUwMzM2MTYzNzllZmZmZF8wLTQtMS0xLTMzMTkz_8f5bde6a-c459-496f-9641-943421944bec">45-4488360</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8xMzQy_f8cc73f6-ab90-4c76-a581-15754f7b7931">34790 Ardentech Court</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8xMzQz_144c3c89-1100-4840-9476-14e5740b9a14">Fremont</ix:nonNumeric>, <ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8xMzM1_23ac07b0-6fff-4785-aa3d-b1352c57e510">CA</ix:nonNumeric> <ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8xMzQw_f6e9f810-8efc-4435-8f3a-eaae6247f01a">94555</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8xMzM2_72f189fa-6315-4bc0-849e-017a4e39130a">510</ix:nonNumeric>) <ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8xMzQx_2cfabb95-7cd9-4983-b44c-568de0d021ad">745-1200</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:4.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6MWRjN2EyNWM2ZGZmNDg4YmFhYmJjMDFhMGQ4MDg1Y2EvdGFibGVyYW5nZToxZGM3YTI1YzZkZmY0ODhiYWFiYmMwMWEwZDgwODVjYV8wLTAtMS0xLTMzMTkz_10a1465f-9113-4293-be39-6ff1384510f1">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6MWRjN2EyNWM2ZGZmNDg4YmFhYmJjMDFhMGQ4MDg1Y2EvdGFibGVyYW5nZToxZGM3YTI1YzZkZmY0ODhiYWFiYmMwMWEwZDgwODVjYV8yLTAtMS0xLTMzMTkz_4d9d4c9d-a521-45ca-876b-6a1f8fa433ec">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6MWRjN2EyNWM2ZGZmNDg4YmFhYmJjMDFhMGQ4MDg1Y2EvdGFibGVyYW5nZToxZGM3YTI1YzZkZmY0ODhiYWFiYmMwMWEwZDgwODVjYV80LTAtMS0xLTMzMTkz_afc689de-ef10-4e9c-b50c-68931d6e35e9">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6MWRjN2EyNWM2ZGZmNDg4YmFhYmJjMDFhMGQ4MDg1Y2EvdGFibGVyYW5nZToxZGM3YTI1YzZkZmY0ODhiYWFiYmMwMWEwZDgwODVjYV82LTAtMS0xLTMzMTkz_d1de540f-340e-421e-afe3-6019e11ba38b">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Exchange Act:</span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:32.131%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6OWIwYzc0NjAwMTJiNGU4NmI0ZjY5ZjllZTZkMGQxMjAvdGFibGVyYW5nZTo5YjBjNzQ2MDAxMmI0ZTg2YjRmNjlmOWVlNmQwZDEyMF8xLTAtMS0xLTMzMTkz_1bf3cc2e-c6a3-45f3-94df-6027af7fe895">Common Stock, $0.0001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6OWIwYzc0NjAwMTJiNGU4NmI0ZjY5ZjllZTZkMGQxMjAvdGFibGVyYW5nZTo5YjBjNzQ2MDAxMmI0ZTg2YjRmNjlmOWVlNmQwZDEyMF8xLTEtMS0xLTMzMTkz_7203c25a-6407-4d6e-ac15-d4f392c60757">ZSAN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGFibGU6OWIwYzc0NjAwMTJiNGU4NmI0ZjY5ZjllZTZkMGQxMjAvdGFibGVyYW5nZTo5YjBjNzQ2MDAxMmI0ZTg2YjRmNjlmOWVlNmQwZDEyMF8xLTItMS0xLTMzMTkz_8ec3c98f-3324-494b-a8ab-0293febadb3c">The Nasdaq Stock Market</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160; <ix:nonNumeric contextRef="ib800c4943b614950b189416f73dc7e99_D20210311-20210311" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzMzI1YjE5MzFkMzQzYTc5MjI1MjliNWI0Nzk3YmVkL3NlYzo2MzMyNWIxOTMxZDM0M2E3OTIyNTI5YjViNDc5N2JlZF8xL2ZyYWc6NDc2NDhmNzc0MDBmNDQyN2E5Zjk2NWU1MTNhNGExOGEvdGV4dHJlZ2lvbjo0NzY0OGY3NzQwMGY0NDI3YTlmOTY1ZTUxM2E0YTE4YV8xMzM3_816615b6-be28-458a-897a-c45c9b767cd5">&#9744;</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;  &#9744;</span></div><div><span><br/></span></div><div id="i63325b1931d343a7922529b5b4797bed_7"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2022, Zosano Pharma Corporation (the &#8220;Company&#8221;) issued a press release titled &#8220;Zosano Pharma Reports First Quarter 2022 Financial Results.&#8221; The press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 2.02.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.02&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2022, Joseph &#8220;Jay&#8221; P. Hagan tendered his resignation as a director of the board of directors (the &#8220;Board&#8221;) of the Company and as chairperson of the audit committee of the Board, effective immediately. Mr. Hagan's resignation is not based on any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practice.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following Mr. Hagan's resignation, on May 10, 2022, pursuant to the authority contained in the Company&#8217;s amended and restated certificate of incorporation, the Board approved decreasing the size of the Board to five members.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;text-decoration:underline">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991q12022earningsre.htm">Press release dated May 13, 2022, titled &#8220;Zosano Pharma Reports First Quarter 2022 Financial Results&#8221;</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div id="i63325b1931d343a7922529b5b4797bed_10"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:41.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.843%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ZOSANO PHARMA CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 13, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christine Matthews</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name: Christine Matthews</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title: Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "zsan-20220510.htm", "description": "8-K", "secsgml_size_bytes": 39680}]
{"company-data": {"conformed-name": "Zosano Pharma Corp", "cik": "0001587221", "assigned-sic": "2834", "irs-number": "454488360", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36570", "film-number": "22922684"}, "business-address": {"street1": "34790 ARDENTECH COURT", "city": "FREMONT", "state": "CA", "zip": "94555", "phone": "510-745-1200"}, "mail-address": {"street1": "34790 ARDENTECH COURT", "city": "FREMONT", "state": "CA", "zip": "94555"}, "former-company": {"former-conformed-name": "ZP Holdings Inc", "date-changed": "20130919"}}
zsan-20220510
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
May 10, 2022
ZOSANO PHARMA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
001-36570
45-4488360
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
34790 Ardentech Court
Fremont
,
CA
94555
(Address of principal executive offices) (Zip Code)
(
510
)
745-1200
Registrant's telephone number, including area code
Not applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value
ZSAN
The Nasdaq Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Item 2.02    Results of Operations and Financial Condition.
On May 13, 2022, Zosano Pharma Corporation (the "Company") issued a press release titled "Zosano Pharma Reports First Quarter 2022 Financial Results." The press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 2.02.
The information in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 10, 2022, Joseph "Jay" P. Hagan tendered his resignation as a director of the board of directors (the "Board") of the Company and as chairperson of the audit committee of the Board, effective immediately. Mr. Hagan's resignation is not based on any disagreement with the Company on any matter relating to the Company's operations, policies or practice.
Following Mr. Hagan's resignation, on May 10, 2022, pursuant to the authority contained in the Company's amended and restated certificate of incorporation, the Board approved decreasing the size of the Board to five members.
Item 9.01    Financial Statements and Exhibits.
(d)
Exhibits
.
Exhibit
Description
99.1
Press release dated May 13, 2022, titled "Zosano Pharma Reports First Quarter 2022 Financial Results"
104.1
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ZOSANO PHARMA CORPORATION
Date: May 13, 2022
By:
/s/ Christine Matthews
Name: Christine Matthews
Title: Chief Financial Officer